428 results on '"Sleasman, John W"'
Search Results
2. Normal IgH Repertoire Diversity in an Infant with ADA Deficiency After Gene Therapy
3. Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis
4. Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy
5. Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency
6. Anti-inflammatory effects of recreational marijuana in virally suppressed youth with HIV-1 are reversed by use of tobacco products in combination with marijuana
7. Case Report: Aplastic anemia related to a novel CTLA4 variant.
8. Case Report: Profound newborn leukopenia related to a novel RAC2 variant
9. Association Between Breast Milk Bacterial Communities and Establishment and Development of the Infant Gut Microbiome
10. A novel transmembrane CXCR4variant that expands the WHIM genotype-phenotype paradigm
11. Differential controls of MAIT cell effector polarization by mTORC1/mTORC2 via integrating cytokine and costimulatory signals
12. Immunodeficiency Diseases of the Neonate
13. A novel transmembrane CXCR4 variant that expands the WHIM genotype-phenotype paradigm
14. AIDS and other acquired immunodeficiencies
15. Primary immunodeficiency diseases
16. Adaptive immune response: Antigens, lymphocytes, and accessory cells
17. Diagnosis of immune deficiency diseases
18. Phagocytic cells and their functions
19. Trajectories of Depressive Symptoms, Neurocognitive Function, and Viral Suppression With Antiretroviral Therapy Among Youth With HIV Over 36 months
20. Chapter 18 - Recent advances and controversies in inborn errors of immunity presenting in the newborn period
21. Biomarkers detected in cord blood predict vaccine responses in young infants
22. Higher soluble CD14 levels are associated with lower visuospatial memory performance in youth with HIV
23. Effect of FcRn antagonism on protective antibodies and to vaccines in IgG-mediated autoimmune diseases pemphigus and generalised myasthenia gravis
24. Concordance between self-reported substance use and toxicology among HIV-infected and uninfected at risk youth
25. Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV
26. Protease Inhibitors and HIV-1 Genetic Variability in Infected Children
27. Additional file 1 of Anti-inflammatory effects of recreational marijuana in virally suppressed youth with HIV-1 are reversed by use of tobacco products in combination with marijuana
28. The Regulatory B Cell Compartment Expands Transiently During Childhood and Is Contracted in Children With Autoimmunity
29. Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (AIDS)
30. Δ9-Tetrahydrocannabinol Treatment During Human Monocyte Differentiation Reduces Macrophage Susceptibility to HIV-1 Infection
31. Combination Antiretroviral Therapy Results in a Rapid Increase in T Cell Receptor Variable Region β Repertoire Diversity within CD45RA CD8 T Cells in Human Immunodeficiency Virus-Infected Children
32. Immunoregulatory CD4+ T Cell Subpopulations: Enumeration, Activation, and Functional Analyses in Normals and Autoimmune Disease
33. Long-Term Virologic and Immunologic Responses in Human Immunodeficiency Virus Type 1-Infected Children Treated with Indinavir, Zidovudine, and Lamivudine
34. Human Immunodeficiency Virus Type 1 Protease Genotype Predicts Immune and Viral Responses to Combination Therapy with Protease Inhibitors (PIs) in PI-Naive Patients
35. Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency
36. Bioavailability of IgG Administered by the Subcutaneous Route
37. Immunodeficiency: Innate, Primary, and Secondary
38. Regulation of Intrinsic and Bystander T Follicular Helper Cell Differentiation and Autoimmunity by Tsc1
39. Psychrobacter immobilis Septicemia in a Boy with X-linked Chronic Granulomatous Disease and Fulminant Hepatic Failure
40. Tolerability of a New 10% Liquid Immunoglobulin for Intravenous Use, Privigen®, at Different Infusion Rates
41. Hypereosinophilic syndrome and hemimelia in a patient with chromosome 6p22.3 deletion
42. Clinical implications of discordant viral and immune outcomes following protease inhibitor containing antiretroviral therapy for HIV-infected children
43. Thymic Epithelial Cell-Derived IL-15 and IL-15 Receptor α Chain Foster Local Environment for Type 1 Innate Like T Cell Development
44. Immunodeficiency diseases of the neonate
45. Molecular docking-based screening for novel inhibitors of the human immunodeficiency virus type 1 protease that effectively reduce the viral replication in human cells
46. Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency
47. Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children
48. Substantial Multiclass Transmitted Drug Resistance and Drug-Relevant Polymorphisms Among Treatment-Naïve Behaviorally HIV-Infected Youth
49. Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort
50. Negative control of diacylglycerol kinase ζ‐mediated inhibition of T cell receptor signaling by nuclear sequestration in mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.